These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 5698437
1. Indomethacin, reduced retinal sensitivity, and corneal deposits. Burns CA. Am J Ophthalmol; 1968 Nov; 66(5):825-35. PubMed ID: 5698437 [No Abstract] [Full Text] [Related]
2. Ocular side effects of indomethacin. Palimeris G, Koliopoulos J, Velissaropoulos P. Ophthalmologica; 1972 Nov; 164(5):339-53. PubMed ID: 4537509 [No Abstract] [Full Text] [Related]
3. [Ocular involvement in chloroquine therapy]. Godel V, Nemet P, Stein R. Harefuah; 1972 Jul 16; 83(2):60-3. PubMed ID: 5068910 [No Abstract] [Full Text] [Related]
4. Indomethacin retinopathy. Henkes HE, van Lith GH, Canta LR. Am J Ophthalmol; 1972 Jun 16; 73(6):846-56. PubMed ID: 4537496 [No Abstract] [Full Text] [Related]
5. Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis. Percival SP, Meanock I. Br Med J; 1968 Sep 07; 3(5618):579-84. PubMed ID: 4875645 [Abstract] [Full Text] [Related]
11. Indomethacin induced ocular toxicity. Burns CA. Am J Ophthalmol; 1973 Aug 07; 76(2):312-3. PubMed ID: 4725014 [No Abstract] [Full Text] [Related]
12. Ocular damage in chloroquine therapy. Nylander U. Acta Ophthalmol (Copenh); 1967 Aug 07; ():Suppl 92:1-71. PubMed ID: 4866642 [No Abstract] [Full Text] [Related]
13. Electroretinography in patients with connective tissue diseases treated with hydroxychloroquine. Sassaman FW, Cassidy JT, Alpern M, Maaseidvaag F. Am J Ophthalmol; 1970 Oct 07; 70(4):515-23. PubMed ID: 5505469 [No Abstract] [Full Text] [Related]
14. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)]. Gol'dovskaia IL. Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Oct 07; 69(6):935-9. PubMed ID: 4905472 [No Abstract] [Full Text] [Related]
15. Some iatrogenic ocular diseases from systemically administered drugs. Bernstein HN. Int Ophthalmol Clin; 1970 Oct 07; 10(3):553-619. PubMed ID: 4933547 [No Abstract] [Full Text] [Related]
17. [JUVENILE MACULAR DEGENERATION AND ITS RELATION TO OTHER SYMPTOMS OF RETINAL DYSTROPHY]. SEBESTYEN J, STRENGER J, SZABO G. Szemeszet; 1964 Mar 07; 101():25-36. PubMed ID: 14144327 [No Abstract] [Full Text] [Related]
18. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average]. Bertrand JJ, Debeyre N, Kahn MF, Ryckewaert A. Presse Med (1893); 1968 Nov 23; 76(45):2139-42. PubMed ID: 5720115 [No Abstract] [Full Text] [Related]